Hematology
The Jacques and Gloria Gossweiler Foundation offers both a Hematology Research Grant and a Hematology Research Physician-Scientist Fellowship Award on a yearly basis in cooperation with the Swiss Society of Hematology.
Application deadline for both: 31. March 2025
Learn more about these unique oportunities:
Fellowship Award Winners
2020: Call No 1:
- Katarzyna Aleksandra Jalowiec, Inselspital Bern: “Molecular Analysis in Patients with Idiopathic Erythrocytosis”
- Sebastian Stolz, Uni Zürich: The mechanisms of chemotherapy-induced clonal expansion in TP53-mutated premalignant blood cells"
2021: Call No 2:
- Adalgisa Condoluci, Institute of Oncology Research, Bellinzona: “Reprogramming the spenic marginal zone lymphoma-educated micrienvironment to RESTORE immune surveillance”
2022: Call No 3:
- Nastassja K. Scheidegger, Dana-Farber Cancer Institute (USA), “Genome-scale CRISPR/Cas9 screen to identify new therapeutic strategies with exportin 1 inhibitors in acute myeloid leukemia harboring NPM l mutations”
- Roman Schimmer, Uni Zürich: “Development of pre-clinical acute myeloid leukemia (AML) models through combinatorial CRISPR/Cas9-mediated genome editing”
2023: Call No 4:
- Kevin Hofer, Uni Zürich: "Prevalence and clinical course of occult bacterial infections after B-cell depletion therapies"
2024: Call No 5:
- Maxime Zermatten, CHUV: "Usefulness of global hemostatic tests in the identification of patients with multiple myeloma at high thrombotic riskThe ThroMMbosis Study"
Research Grant Winners
2020: Call No 1:
- Lorenzo Alberio, CHUV, “BioCAP - Platelet biotinylation for in vivo functional analysis in humans”
- Alexander Pierre André Theocharides, University Hospital Zurich: "The role of protein degradation pathways in calreticulin mutated myeloproliferative neoplasms"
2021: Call No 2:
- Davide Rossi, Institute of Oncology Research, Bellinzona: “Adaption of chronic lymphatic leukemia to BTK inhibitors is mediated by by-pass signaling via MAPK pathway: implications for targeting minimal residual disease”
- Böttcher Steffen, University Hospital Zurich: “From clonal hematopoiesis to therapy - related myeloid neoplasms”
2022: Call No 3:
- Markus Schmugge, University Children’s Hospital Zurich: “Molekular crosstalk mechanisms between apoptosis and autophagy in platelets and megakaryocytes in immune thrombocytopenia” (Schmugge et al B J Haematol 2023 und Editorial durch Kapur und Stein et al VTH Blood 2024, in press)
2023: Call No 4:
- Linet Njue, University of Bern (Inselspital): “Gas6/Axl analysis in patients with sickle-cell anemia”
- Alicia Rovó, University of Bern (Inselspital): “Clinical and functional investigation of novel molecules involved in bone marrow fibrosis in MPN”
2024: Call No 5:
- Stefanie Kreutmair, University of Zurich: “Distinct Immune lndscapes in NPM1C acute amyloid leukemia”
- Jürg Schwaller, Department of Biomedicine University of Basel: "Lineage-biased stem cells in JAK2-driven myeloproliferative neoplasms (MPN)"
- Böttcher Steffen, University Hospital Zurich: “From clonal hematopoiesis to therapy - related myeloid neoplasms”